
Results
2
2 companies
MedinCell
Market Cap: €872.7m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.30
7D
-0.8%
1Y
40.5%
DBV Technologies
Market Cap: €721.4m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.44
7D
-5.1%
1Y
47.6%